Meet the companies selected for the Medicon Village Investor Panel 2026

We are pleased to announce the companies selected to pitch at this year’s Medicon Village Investor Panel, taking place on 17 September 2026.

Following a competitive application process that drew a high number of strong applicants from the regional life science ecosystem, a carefully selected group of companies – all based at Medicon Village – has been invited to present their innovations to a panel of leading investors spanning multiple stages of capital.

The initiative is designed to help early- and growth-stage life science companies strengthen their investment readiness by providing potential investment exposure, visibility, as well as actionable feedback from experienced investors. This year’s selected companies reflect a diverse mix of therapeutic areas, technologies, and business models – ranging from pharma, biotech and medtech to diagnostics and digital health.

The following companies have been selected to pitch:

Asgard Therapeutics
Aventera Antibodies
Dx4Life
Gedea Biotech
ImmuneBiotech
Lead Biologics
rAAVen Therapeutics
Xaga Surgical

Throughout the coming months, the selected companies will take part in tailored preparation activities such as pitch feedback sessions, to help them make the most of the panel opportunity.

We look forward to showcasing these exciting companies and supporting them on their continued growth journey.